Efficacy of Perioperative Immunonutrition in Esophageal Cancer Patients Undergoing Esophagectomy

The incidence of esophageal cancer has been increasing in Japan, with 23,119 new cases diagnosed in 2011, and 11,543 patients dying of this disease in 2013, accounting for 3.2% of all cancer-related deaths [1]. Despite improvements in surgical techniques, management of surgical infections, and the development of successive generations of more powerful antibiotics, postoperative infectious and septic complications continue to be major factors contributing to unfavorable clinical outcomes in patients with esophageal cancer undergoing esophagectomy [2 –4].

Source: Nutrition - August 22, 2018 Category: Nutrition Authors: Shinsuke Kanekiyo, Shigeru Takeda, Michihisa Iida, Mitsuo Nishiyama, Masahiro Kitahara, Yoshitaro Shindo, Yukio Tokumitsu, Shinobu Tomochika, Ryoichi Tsunedomi, Nobuaki Suzuki, Toshihiro Abe, Shigefumi Yoshino, Shoichi Hazama, Tomio Ueno, Hiroaki Nagano Source Type: research